Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Fuji
Julphar
Johnson and Johnson
Accenture
UBS
Chubb
Fish and Richardson
Cerilliant

Generated: November 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021336

« Back to Dashboard

NDA 021336 describes EMSAM, which is a drug marketed by Somerset and is included in one NDA. It is available from one supplier. There are three patents protecting this drug. Additional details are available on the EMSAM profile page.

The generic ingredient in EMSAM is selegiline. There are seventeen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the selegiline profile page.
Summary for 021336
Tradename:EMSAM
Applicant:Somerset
Ingredient:selegiline
Patents:3
Formulation / Manufacturing:see details
Pharmacology for NDA: 021336
Medical Subject Heading (MeSH) Categories for 021336
Suppliers and Packaging for NDA: 021336
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336 NDA Mylan Specialty L.P. 49502-900 49502-900-05 5 POUCH in 1 CARTON (49502-900-05) > 1 PATCH in 1 POUCH (49502-900-11) > 24 h in 1 PATCH
EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336 NDA Mylan Specialty L.P. 49502-900 49502-900-30 30 POUCH in 1 CARTON (49502-900-30) > 1 PATCH in 1 POUCH (49502-900-01) > 24 h in 1 PATCH

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength6MG/24HR
Approval Date:Feb 27, 2006TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:May 10, 2018Product Flag?YSubstance Flag?YDelist Request?
Patent:➤ Try a Free TrialPatent Expiration:Jun 12, 2018Product Flag?YSubstance Flag?YDelist Request?
Patent:➤ Try a Free TrialPatent Expiration:May 10, 2018Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 021336

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-003 Feb 27, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-001 Feb 27, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-001 Feb 27, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-002 Feb 27, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-003 Feb 27, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-002 Feb 27, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-002 Feb 27, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
US Army
Merck
Cantor Fitzgerald
Accenture
Baxter
Argus Health
Johnson and Johnson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.